BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023 :

MARLBOROUGH, Mass., Oct. 26, 2023 /PRNewswire/ -- Boston Scientific Corporation generated net sales of $3.527 billion during the third quarter of 2023, growing 11.2 percent on a reported basis,...

Related Keywords

United States , Japan , Boston , Massachusetts , Canada , New Zealand , Australia , Japanese , America , Inari Flowtriever , Lauren Tengler , Mike Mahoney , Emily Anderson , Wavewriter Alpha , Facebook , Securities Exchange , Drug Administration , Twitter , Boston Scientific Corporation , Prnewswire Boston Scientific Corporation , Relievant Medsystems Inc , Japanese Pharmaceuticals , Exchange Commission , Exchange Commission Or Part , Boston Scientific , Devices Agency , Scientific Corporation , Investor Day , Middle East , Pulsed Field Ablation , Cryoablation System , Balloon Catheter , Pro Left Atrial Appendage Closure , Insertable Cardiac Monitor , Medical Devices Agency , Multi Modality Guidance System , Transcatheter Cardiovascular Therapeutics , Drug Coated , Endovascular System , Electrocautery Enhanced Delivery , Spinal Cord Stimulator , Relievant Medsystems , Intraosseous Nerve Ablation System , Emerging Markets , Central Europe , Full Year , Fourth Quarter , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Months Ended September , Mandatory Convertible Preferred Stock , Estimated Annual Effective Tax Rate , Financial Condition , Quarterly Report , Markets ,